Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Manon De Vries"'
Autor:
Laurence Albiges, Bernard Escudier, Gwenaelle Gravis, Ronan Flippot, Alain Ravaud, Maxime Meylan, Nathalie Rioux-Leclercq, Marine Gross-Goupil, Gaëlle Fromont, Christophe Passot, Lionnel Geoffrois, Fréderic Rolland, Manon de Vries-Brilland, Jonathan Dauvé, Elena Spirina-Menand, Christine Chevreau, Ellen Blanc, Félix Lefort, Sylvie Negrier
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)
Background Papillary renal cell carcinoma (pRCC) is the most common non-clear cell RCC, and associated with poor outcomes in the metastatic setting. In this study, we aimed to comprehensively evaluate the immune tumor microenvironment (TME), largely
Externí odkaz:
https://doaj.org/article/e2ce2468aad14a5187730a92accb65ce
Autor:
Cassandre Gluszak, Manon de Vries-Brilland, Valérie Seegers, Céline Baroin, Helene Kieffer, Remy Delva, Delphine Cornuault-Foubert
Publikováno v:
The Oncologist. 27:328-333
Background Iron deficiency (ID) is very common in patients with solid tumors and may cause symptoms such as fatigue. However, its impact on clinical outcomes is poorly described. The aim of this prospective monocentric cohort study was to evaluate th
Autor:
Elena Spirina Menand, Manon De Vries-Brilland, Leslie Tessier, Jonathan Dauvé, Mario Campone, Véronique Verrièle, Nisrine J, Jean-Marie Marion, Pierre Chauvet, Christophe Passot, Alain Morel
Ovarian cancer is a complex disease with poor outcome affecting women worldwide. The lack of successful therapeutic options for ovarian cancer patients results in the strong need to identify new biomarkers for patient selection. The development of ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e48776a6faa665d47543309d2f9f807
https://doi.org/10.21203/rs.3.rs-2259784/v1
https://doi.org/10.21203/rs.3.rs-2259784/v1
Autor:
Jonathan Farhi, Mélanie Mercier, Valérie Seegers, Norbert Ifrah, Aline Tanguy-Schmidt, Mathilde Hunault-Berger, Sylvain Thepot, Marie-Pierre Moles, Carole Lacout, Aline Clavert, Manon De Vries, Corentin Orvain
Publikováno v:
European Journal of Haematology
European Journal of Haematology, 2020, 105 (2), pp.223-230. ⟨10.1111/ejh.13429⟩
European Journal of Haematology, Wiley, 2020, 105 (2), pp.223-230. ⟨10.1111/ejh.13429⟩
European Journal of Haematology, 2020, 105 (2), pp.223-230. ⟨10.1111/ejh.13429⟩
European Journal of Haematology, Wiley, 2020, 105 (2), pp.223-230. ⟨10.1111/ejh.13429⟩
International audience; Background: The R-DHAP regimen (rituximab, cisplatin, dexamethasone, and high-dose cytarabine) is standardly used to treat relapsed Non-Hodgkin lymphoma (NHL). Despite scarce data, cisplatin is frequently substituted with oxal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb297addcd1b39ab9ae8e4d798298dad
https://www.hal.inserm.fr/inserm-03498857
https://www.hal.inserm.fr/inserm-03498857
Autor:
Sylvie Negrier, Alain Ravaud, Philippe Barthélémy, Olivier Huillard, Valérie Seegers, Carolina Saldana, Delphine Borchiellini, Manon de Vries-Brilland, Bernard Escudier, Sylvain Ladoire, Elouen Boughalem, Constance Thibault, Gwenaelle Gravis, Antoine Thiery-Vuillemin, Lionnel Geoffrois, Laurence Albiges, Christine Chevreau, Marine Gross-Goupil, Benoit Beuselinck
Publikováno v:
European journal of cancer (Oxford, England : 1990). 136
Background Papillary renal cell carcinoma (pRCC) is the most common non-clear cell RCC (nccRCC). Pivotal studies evaluating immune checkpoint inhibitors mostly excluded nccRCC. The aim of this retrospective and multicentre study was to evaluate the a
Autor:
Jean-Yves Blay, Alain Ravaud, Marine Gross-Goupil, Baptiste Sionneau, Manon de Vries-Brilland, Caroline Dutriaux
Publikováno v:
Clinical genitourinary cancer. 17(4)
Autor:
Marine Gross-Goupil, Laurence Albiges, Alain Ravaud, Olivier Huillard, Philippe Barthélémy, Antoine Thiery-Vuillemin, Christine Chevreau, Sylvie Negrier, Elouen Boughalem, Carolina Saldana, Delphine Borchiellini, Manon de Vries-Brilland, Gwenaelle Gravis, Sylvain Ladoire, Bernard Escudier, Constance Thibault, Lionnel Geoffrois, Valérie Seegers, Benoit Beuselinck
Publikováno v:
Journal of Clinical Oncology. 37:582-582
582 Background: pRCC is the most common non-clear cell RCC (nccRCC) and represents up to 15% of RCC. Pivotal studies evaluating ICI mostly excluded nccRCC. Therefore the efficacy of ICI in pRCC remains to be demonstrated. Methods: We retrospectively
Autor:
Mélanie Mercier, Marie-Pierre Moles, Valérie Seegers-Thepot, Carole Lacout, Aline Clavert, Manon De Vries, Jonathan Farhi, Mathilde Hunault, Norbert Ifrah, Aline Tanguy-Schmidt
Publikováno v:
Blood. 126:3959-3959
Background: R-DHAP regimen (rituximab, cisplatin, dexamethasone, high dose cytarabine) based on the 1988 Velasquez's study is a standard scheme used to treat relapsed Non-Hodgkin lymphomas (NHL). Cisplatin is frequently substituted with oxaliplatin t